Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation von Labenski, Heike, Hedtfeld, Silke, Becker, Tim, Tümmler, Burkhard, Stanke, Frauke

Volltext

Flexible Ureterorenoscopy for Treatment of Kidney Stones: Establishment as Primary Standard Therapy in a Tertiary Stone Center von Ising, Stephan, Labenski, Heike, Baltes, Stefan, Khaffaf, Aso, Thomas, Christian, Wiesner, Christoph

Volltext

Derœ Interferon-[gamma]-Rezeptor 1 (IFNGR1) :ein genetischer Modulator der Mukoviszidose? von Labenski, Heike Christine

Volltext bestellen

SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine von Wobst, Heike J, Viader, Andreu, Muncipinto, Giovanni, Hollibaugh, Ryan, van Kalken, Daniel, Burkhart, Christopher T, Cantin, Susan M, Bates, Rachel M, Regimbald-Dumas, Yannik, Gross, Liam, Antalek, Mitchell T, Zweig, Joshua E, Wu, Frank, Rettenmaier, T Justin, Labenski, Matthew T, Pullen, Nicholas, Blanchette, Heather S, Henderson, Jaclyn L, Weng, Haoling H, Vaughn, Toby A, Brown, Dean G, Throup, John P, Barrish, Joel C

Volltext